Egger K, Werner M, Meining A, Ott R, Allescher H-D, Höfler H, Classen M, Rösch T
Department of Internal Medicine II, Technical University of Munich, Munich, Germany.
Gut. 2003 Jan;52(1):18-23. doi: 10.1136/gut.52.1.18.
Endoscopic surveillance including stepwise four quadrant biopsies (4QB) is still regarded as the standard approach in patients with Barrett's oesophagus (BO). Several methods such as dye staining with methylene blue (MB) and tissue autofluorescence (AF) have been advocated to reduce the number of biopsies. We assessed their sensitivity and specificity compared with the standard approach-that is, endoscopy with 4QB-in the surveillance of a mixed BO population.
Thirty five consecutive BO patients (mean age 64.9 years; 30 men, five women) were included in the study. AF endoscopy was followed by high resolution video endoscopy (VE) plus tissue staining with 0.5% MB. Biopsies were taken from any suspicious area found on any of the above tests, in addition to 4QB every 2 cm. The results were classified as either positive or negative for the various tests used. Histopathological results were used as the reference standard.
In the 35 study patients, a total of 345 biopsies showed low grade dysplasia (LGD) in 88 biopsies, high grade dysplasia (HGD) in 19 biopsies, and carcinoma in 12 biopsies. The sensitivity and specificity rates for AF and MB for the diagnosis of cancer or dysplasia versus BO mucosa without dysplasia were 21%/91% and 37%/91%, respectively. 4QB revealed five cancer/HGD areas and 76 LGD areas not detected by AF, MB, or VE. The additional yield of MB and AF over VE with 4QB concerned only one HGD area (in the vicinity of a cancer) and seven LGD areas.
Due to their low sensitivity, AF and MB are not suitable techniques for reducing the high numbers of routine biopsies needed for finding additional foci of HGD or cancer. Careful endoscopic observation and stepwise four quadrant biopsy therefore still represent the gold standard for surveillance of Barrett's oesophagus.
内镜监测,包括逐步四象限活检(4QB),仍被视为巴雷特食管(BO)患者的标准方法。已提倡多种方法,如亚甲蓝(MB)染色和组织自体荧光(AF),以减少活检次数。我们在混合性BO人群的监测中,评估了它们与标准方法(即4QB内镜检查)相比的敏感性和特异性。
35例连续的BO患者(平均年龄64.9岁;30例男性,5例女性)纳入本研究。先进行AF内镜检查,然后进行高分辨率视频内镜检查(VE)并加用0.5%MB组织染色。除每2cm进行4QB外,还从上述任何检查发现的任何可疑区域取材活检。将各种检查结果分类为阳性或阴性。组织病理学结果用作参考标准。
在35例研究患者中,总共345次活检显示88次活检为低级别异型增生(LGD),19次活检为高级别异型增生(HGD),12次活检为癌。AF和MB诊断癌症或异型增生与无异型增生的BO黏膜相比,敏感性和特异性分别为21%/91%和37%/91%。4QB发现了5个癌症/HGD区域以及76个未被AF、MB或VE检测到的LGD区域。MB和AF相对于4QB-VE的额外检出率仅涉及1个HGD区域(在癌症附近)和7个LGD区域。
由于AF和MB敏感性低,它们并非减少发现HGD或癌症额外病灶所需大量常规活检的合适技术。因此,仔细的内镜观察和逐步四象限活检仍是巴雷特食管监测的金标准。